Hao Zhang
Director/Board Member at Ambio Pharmaceuticals
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen John Kiel | M | 71 |
Ambio Pharmaceuticals
 Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Jun Cai Bai | M | 61 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Wei Jia Shen | M | 70 |
Fudan University
| 25 years |
| Peter Joe Pitts | M | 65 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Chong Sun Chung | M | 48 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 years |
| Craig Marshall Lea | M | 71 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 years |
| Ming Chuan Ren | M | 64 |
Fudan University
| 24 years |
| Xuelei Lin | M | 59 |
Fudan University
| 24 years |
| Lu Yang Zhang | M | 67 |
Fudan University
| 24 years |
| Wei Zhang | M | 56 |
Fudan University
| 25 years |
| Ling Yang | F | 44 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 4 years |
| Michael William Pennington | M | 62 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 years |
| Xiao Bo Lu | M | 51 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 3 years |
| Shing Cheung Wong | M | 37 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | - |
| Timothy Nieters | M | 52 |
Ambio Pharmaceuticals
Ambio Pharmaceuticals Miscellaneous Commercial ServicesCommercial Services Ambio Pharmaceuticals engages in the business of providing contract manufacturing services of biosimilar and bioequivalent peptide drugs and research and development of peptides and biopharmaceuticals. It operates through the CDMO Business and Drug Development segments. The CDMO Business segment develops and provides contract manufacturing services for peptides and biopharmaceuticals at clinical trial stage. The Drug Development segment focuses on biosimilar and bioequivalent drugs. The company was founded on October 8, 2020 and is headquartered in North Augusta, SC. | 9 years |
| Tao Ma | M | 67 |
Fudan University
| 23 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hoossam Malek | M | - |
The University of Chicago
| 3 years |
| Yu Bing Chen | M | 47 |
Fudan University
| 7 years |
| Laszlo Korsos | M | - |
The University of Chicago
| 5 years |
| Yu Ming Zhang | M | 62 |
Fudan University
| 11 years |
| Justin Kern | M | - |
The University of Chicago
| 10 years |
| Pei Xian Wang | M | 53 |
Fudan University
| 6 years |
| Yan Xu | F | 47 |
Fudan University
| 6 years |
| Ke Cheng | M | - |
The University of Chicago
| 3 years |
| Ying Chun Zhu | M | 47 |
Fudan University
| 7 years |
| Kimerling Daniel | M | - |
The University of Chicago
| 4 years |
| Li Hua Zheng | M | 46 |
Fudan University
| - |
| Xin Hui Zhang | M | 46 |
Fudan University
| 6 years |
| Rodney Nelson | M | - |
The University of Chicago
| 4 years |
| Ying Chun Zhu | M | 46 |
Fudan University
| 6 years |
| Yong Zhao | M | 47 |
Fudan University
| 6 years |
| Liming Huang | M | 46 |
Fudan University
| 6 years |
| Matt Hutchison | M | - |
The University of Chicago
| 3 years |
| Xiao Peng Guo | M | 41 |
Fudan University
| 7 years |
| Wen Hua | M | 50 |
Fudan University
| 4 years |
| Zhe Wang | M | 53 |
Fudan University
| 1 years |
| Yi Yang | M | - |
Fudan University
| 6 years |
| Ya Chao Zhao | F | 41 |
Fudan University
| 7 years |
| Ying Zhu | F | - |
Fudan University
The University of Chicago
| 5 years |
| Zhi Hua Zhang | M | 43 |
Fudan University
| 5 years |
| Hong Jun An | M | 55 |
Fudan University
| 5 years |
| Anthony Nese | M | - |
The University of Chicago
| 4 years |
| Jasmina Marjanovic | F | - |
The University of Chicago
| 6 years |
| Geaney Kevin | M | - |
The University of Chicago
| 4 years |
| Yutaro Kasai | M | - |
The University of Chicago
| 2 years |
| Jordan Levin | M | - |
The University of Chicago
| 2 years |
| Alex A. Frey | M | - |
The University of Chicago
| 4 years |
| Andrew Han | M | - |
The University of Chicago
| 4 years |
| Dan Sheng | M | 47 |
The University of Chicago
| 2 years |
| Steven Li | M | - |
The University of Chicago
| 3 years |
| Akhil Subramanian | M | - |
The University of Chicago
| 4 years |
| Illya Zyskind | M | - |
The University of Chicago
| 2 years |
| Jackson S Jenkins | M | - |
The University of Chicago
| 4 years |
| Spencer Ingle | M | - |
The University of Chicago
| 4 years |
| Kevin Cai | M | - |
The University of Chicago
| 4 years |
| Tarun Gupta | M | - |
The University of Chicago
| 5 years |
| bo shi | M | - |
The University of Chicago
| 4 years |
| Joseph Eric Walsh | M | - |
The University of Chicago
| 4 years |
| Marta Ryvak | F | - |
The University of Chicago
| 4 years |
| Steven Wang | M | - |
The University of Chicago
| 10 years |
| Bo Shi | M | - |
The University of Chicago
| 4 years |
| Amanda Schlumpf | F | - |
The University of Chicago
| 4 years |
| Amer Hasan | M | - |
The University of Chicago
| 5 years |
| Adam Janofsky | M | - |
The University of Chicago
| 4 years |
| Paul Hamilos | M | - |
The University of Chicago
| 2 years |
| Dong Eun Chi | M | 33 |
The University of Chicago
| 4 years |
| Evan Marks Kominsky | M | - |
The University of Chicago
| 2 years |
| Eric Mitchel Parmenter | M | - |
The University of Chicago
| 2 years |
| Rick Yuan | M | - |
The University of Chicago
| 4 years |
| Bernardo Costa | M | - |
The University of Chicago
| 2 years |
| Monika Garg | F | - |
The University of Chicago
| 2 years |
| Tim Skiendzielewski | M | 43 |
The University of Chicago
| 2 years |
| Guy Lakonishok | M | - |
The University of Chicago
| 2 years |
| Daniel Anthony Dittler | M | - |
The University of Chicago
| 2 years |
| Thomas Tan | M | - |
The University of Chicago
| 2 years |
| Lauren Michelle MacIntosh | F | - |
The University of Chicago
| 4 years |
| Daniel Holland | M | - |
The University of Chicago
| 2 years |
| Reetu Kumra | F | - |
The University of Chicago
| 2 years |
| Stephen P. Master | M | - |
The University of Chicago
| 2 years |
| Matthew J. Lombardo | M | - |
The University of Chicago
| 3 years |
| Edward J. Largent | M | - |
The University of Chicago
| 4 years |
| Liliya Ivanova | F | - |
The University of Chicago
| 4 years |
| Ronald Kei Ching Chan | M | - |
The University of Chicago
| 3 years |
| David Graham | M | - |
The University of Chicago
| 2 years |
| Trevor Rice Kaufman | M | - |
The University of Chicago
| 2 years |
| Gleb Kozyritskiy | M | - |
The University of Chicago
| 2 years |
| Brian Weinstein | M | - |
The University of Chicago
| 2 years |
| Matthew Tyler Brennan | M | - |
The University of Chicago
| 4 years |
| Hersh Shintre | M | - |
The University of Chicago
| 4 years |
| Emily Xia-Reinert | F | - |
The University of Chicago
| 4 years |
| Kenta Shimojo | M | - |
The University of Chicago
| 2 years |
| Greg Leonberger | M | - |
The University of Chicago
| 3 years |
| Peter Chung | M | - |
The University of Chicago
| 1 years |
| Austin Evelyn Head-Jones | F | - |
The University of Chicago
| 2 years |
| Victor Ko | M | - |
The University of Chicago
| 4 years |
| Yu Shao | M | 49 |
The University of Chicago
| 2 years |
| Kabir Iyengar | M | - |
The University of Chicago
| 4 years |
| Daniel Gruemmer | M | - |
The University of Chicago
| 2 years |
| Scott James Duba | M | - |
The University of Chicago
| 2 years |
| Shaun Cabrita | M | - |
The University of Chicago
| - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 77 | 77.00% |
| China | 24 | 24.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hao Zhang
- Personal Network
